Treatment of atopic dermatitis - time to revise our strategy?

Dr. Olivry graduated from the University of Toulouse, France, and completed a residency and PhD at the University of California Davis. He is a Diplomate of the ECVD and the ACVD. After 28 years as a clinician-scientist in veterinary dermatology and allergy at the NC State University College of Veterinary Medicine. Dr. Olivry left academia and moved back to Europe. In November 2022, he became Head of Research & Development at Nextmune, a multinational animal health company headquartered in Stockholm, Sweden.
Sign up
To reserve your spot, simply complete and submit the form below:
About the speaker

Dr. Thierry Olivry
DVM, PhD, ECVD Dipl.
Dr. Olivry graduated from the University of Toulouse, France, and completed a residency and PhD at the University of California Davis. He is a Diplomate of the ECVD and the ACVD. After 28 years as a clinician-scientist in veterinary dermatology and allergy at the NC State University College of Veterinary Medicine. Dr. Olivry left Academia and moved back to Europe to live in Riga, Latvia. In November 2022, he became Head of Research & Development at Nextmune, a multinational animal health company headquartered in Stockholm, Sweden.